Inventor · disambiguated record
Anne B. Eldrup
Also filed as: ELDRUP ANNE · ELDRUP ANNE B · ELDRUP ANNE BETTINA
18 granted patents·33 pending applications·1,418 citations·filing 1997–2021
96Inventor score
Files withBHAT BALKRISHEN5ISIS PHARMACEUTICALS INC5ALLERSON CHARLES4IONIS PHARMACEUTICALS INC4MERCK & CO INC4
Top patents by PatentIndex Score
51 records- 0198US7202224B2Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseISIS PHARMACEUTICALS INC·Filed 2006·Granted Apr 10, 2007·222 cites·1 claims
- 0298US7125855B2Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseMERCK & CO INC·Filed 2003·Granted Oct 24, 2006·301 cites·4 claims
- 0398US7105499B2Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseISIS PHARMACEUTICALS INC·Filed 2002·Granted Sep 12, 2006·233 cites·2 claims
- 0498US6777395B2Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virusMERCK & CO INC·Filed 2002·Granted Aug 17, 2004·356 cites·13 claims
- 0597US7534767B2C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymeraseMERCK & CO INC·Filed 2005·Granted May 19, 2009·69 cites·23 claims
- 0696US10266825B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationIONIS PHARMACEUTICALS INC·Filed 2017·Granted Apr 23, 2019·10 cites·21 claims
- 0794US7323453B2Methods of inhibiting orthopoxvirus replication with nucleoside compoundsMERCK & CO INC·Filed 2003·Granted Jan 29, 2008·71 cites·27 claims
- 0891US8481712B2Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseBHAT BALKRISHEN·Filed 2007·Granted Jul 9, 2013·48 cites·11 claims
- 0991US7919612B22′-substituted oligomeric compounds and compositions for use in gene modulationsISIS PHARMACEUTICALS INC·Filed 2003·Granted Apr 5, 2011·14 cites·12 claims
- 1090US8604183B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationALLERSON CHARLES·Filed 2003·Granted Dec 10, 2013·20 cites·24 claims
- 1186US9150606B2Compositions comprising alternating 2'-modified nucleosides for use in gene modulationALLERSON CHARLES·Filed 2005·Granted Oct 6, 2015·9 cites·21 claims
- 1285US7812149B22′-Fluoro substituted oligomeric compounds and compositions for use in gene modulationsISIS PHARMACEUTICALS INC·Filed 2003·Granted Oct 12, 2010·12 cites·22 claims
- 1382US9150605B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationALLERSON CHARLES·Filed 2004·Granted Oct 6, 2015·9 cites·22 claims
- 1479US6617422B1Peptide nucleic acid monomers and oligomersNIELSEN PETER·Filed 1997·Granted Sep 9, 2003·36 cites·41 claims
- 1577US2022162603A1Compositions comprising alternating 2'-modified nucleosides for use in gene modulationIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1674US11078485B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationIONIS PHARMACEUTICALS INC·Filed 2019·Granted Aug 3, 2021·0 cites·7 claims
- 1762US2008039618A1Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulationALLERSON CHARLES·Filed 2007·Application pending·0 cites
- 1859US2017183373A1Nucleoside derivatives as inhibitors of rna-dependent rna viral polyermaseMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 1959US2006205686A1Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseBHAT BALKRISHEN·Filed 2005·Application pending·0 cites
- 2059US2007275912A1Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymeraseBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 2158US2004147470A1Cross-linked oligomeric compounds and their use in gene modulationFiled 2003·Application pending·0 cites
- 2257US2004186071A1Antisense modulation of CD40 expressionFiled 2003·Application pending·0 cites
- 2356US2005053976A1Chimeric oligomeric compounds and their use in gene modulationFiled 2004·Application pending·0 cites
- 2456US2005272676A1Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseBHAT BALKRISHEN·Filed 2005·Application pending·0 cites
- 2554US6632919B1Peptide nucleic acid monomers and oligomersNIELSEN PETER·Filed 1998·Granted Oct 14, 2003·8 cites·42 claims
- 2653US2005042647A1Phosphorous-linked oligomeric compounds and their use in gene modulationFiled 2004·Application pending·0 cites
- 2752US2004171032A1Non-phosphorous-linked oligomeric compounds and their use in gene modulationFiled 2003·Application pending·0 cites
- 2852US2004171028A1Phosphorous-linked oligomeric compounds and their use in gene modulationFiled 2003·Application pending·0 cites
- 2952US2004161844A1Sugar and backbone-surrogate-containing oligomeric compounds and compositions for use in gene modulationFiled 2003·Application pending·0 cites
- 3052US2004171030A1Oligomeric compounds having modified bases for binding to cytosine and uracil or thymine and their use in gene modulationFiled 2003·Application pending·0 cites
- 3152US2004072788A1Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseFiled 2003·Application pending·0 cites
- 3252US2005119470A1Conjugated oligomeric compounds and their use in gene modulationFiled 2003·Application pending·0 cites
- 3352US2005118605A9Oligomeric compounds having modified bases for binding to adenine and guanine and their use in gene modulationFiled 2003·Application pending·0 cites
- 3452US2004203024A1Modified oligonucleotides for use in RNA interferenceFiled 2003·Application pending·0 cites
- 3552US2004171031A1Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulationFiled 2003·Application pending·0 cites
- 3651US2011118262A1Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 InhibitiorsBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 3750US8258301B2Urotensin II receptor antagonistsCOOK BRIAN NICHOLAS·Filed 2008·Granted Sep 4, 2012·0 cites·3 claims
- 3850US2004014108A1Oligonucleotides having modified nucleoside unitsFiled 2003·Application pending·0 cites
- 3949US2016017324A1Chimeric oligomeric compounds and their use in gene modulationISIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4049US2004147022A12'-methoxy substituted oligomeric compounds and compositions for use in gene modulationsFiled 2003·Application pending·0 cites
- 4149US2004161777A1Modified oligonucleotides for use in RNA interferenceFiled 2003·Application pending·0 cites
- 4248US2004014957A1Oligonucleotides having modified nucleoside unitsFiled 2003·Application pending·0 cites
- 4347US2007004669A1Nucleoside derivatives as inhibitors of rna-dependent rna viral polymeraseCARROLL STEVEN S·Filed 2003·Application pending·0 cites
- 4447US2004229840A1Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseFiled 2003·Application pending·0 cites
- 4545US2009111791A1Soluble Epoxide Hydrolase Inhibitors and Methods of Using SameBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 4645US2006234962A1Nucleoside derivatives as inhibitors of rna-dependent rna viral polymeraseOLSEN DAVID B·Filed 2003·Application pending·0 cites
- 4744US9771578B2Phosphorous-linked oligomeric compounds and their use in gene modulationIONIS PHARMACEUTICALS INC·Filed 2015·Granted Sep 26, 2017·0 cites·12 claims
- 4844US2006264389A1Nucleoside derivatives as inhibitors of rna-dependent rna viral polymeraseBHAT BALKRISHEN·Filed 2003·Application pending·0 cites
- 4943US2008280904A1N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase InhibitorsELDRUP ANNE BETTINA·Filed 2006·Application pending·0 cites
- 5043US2009099184A1Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitorsBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →